Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2004-08, Vol.19 (8), p.2137-2139
Hauptverfasser:	Summers, Shaun A., Matijevic, Ante, Almond, Mike K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibodies - immunology Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system cyclosporine Cyclosporine - therapeutic use Darbepoetin alfa Drug Resistance Drug toxicity and drugs side effects treatment Emergency and intensive care: renal failure. Dialysis management Epoetin Alfa Erythropoietin - administration & dosage Erythropoietin - adverse effects Erythropoietin - analogs & derivatives Erythropoietin - immunology Erythropoietin - therapeutic use haemoglobin Humans Immunosuppressive Agents - therapeutic use Intensive care medicine Male Medical sciences Pharmacology. Drug treatments pure red cell aplasia recombinant human erythropoietin Recombinant Proteins Red-Cell Aplasia, Pure - chemically induced Red-Cell Aplasia, Pure - immunology Renal Dialysis Reticulocyte Count Retreatment Toxicity: urogenital system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!